These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3371399)

  • 1. Effects of neuropeptide Y on canine cerebral circulation.
    Suzuki Y; Shibuya M; Ikegaki I; Satoh S; Takayasu M; Asano T
    Eur J Pharmacol; 1988 Feb; 146(2-3):271-7. PubMed ID: 3371399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin causes contraction of canine and bovine arterial smooth muscle in vitro and in vivo.
    Suzuki Y; Satoh S; Ikegaki I; Asano T; Shibuya M; Sugita K; Lederis K; Rorstad O
    Acta Neurochir (Wien); 1990; 104(1-2):42-7. PubMed ID: 2201171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
    Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
    Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y.
    Laher I; Germann P; Bevan JA
    Can J Physiol Pharmacol; 1994 Sep; 72(9):1086-8. PubMed ID: 7842391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of increasing doses of alpha-trinositol on cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Edvinsson L; Paulson OB
    Pharmacol Toxicol; 1997 Jan; 80(1):38-43. PubMed ID: 9148281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries.
    Abel PW; Han C
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):52-63. PubMed ID: 2468936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcitonin gene-related peptide on canine cerebral artery strips and the in-vivo vertebral blood flow in dogs.
    Ikegaki I; Suzuki Y; Satoh S; Asano T; Shibuya M; Sugita K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):431-6. PubMed ID: 2479844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
    Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
    J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve fibers containing neuropeptide Y in the cerebrovascular bed: immunocytochemistry, radioimmunoassay, and vasomotor effects.
    Edvinsson L; Copeland JR; Emson PC; McCulloch J; Uddman R
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):45-57. PubMed ID: 3805164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
    Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
    Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
    Edvinsson L
    Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of neuropeptide Y and norepinephrine in the porcine ovarian artery and their influence on the local blood pressure.
    Markiewicz W; Jaroszewski JJ; Barszczewska B; Sienkiewicz W
    Folia Histochem Cytobiol; 2003; 41(2):73-81. PubMed ID: 12722792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of K+ channels in neuropeptide Y-induced vasoconstriction in rabbit cerebral basilar artery.
    Xia Y; Han C
    Eur J Pharmacol; 1994 Apr; 255(1-3):67-72. PubMed ID: 8026555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and the cerebral circulation.
    Tuor UI; Kelly PA; Edvinsson L; McCulloch J
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):591-601. PubMed ID: 2384533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.